The ACME Laboratories Ltd. (DSE:ACMELAB)
Bangladesh · Delayed Price · Currency is BDT 75.30
-0.30 (-0.40%)
At close: Apr 13, 2026
The ACME Laboratories Market Cap
The ACME Laboratories has a market cap or net worth of 15.93 billion as of April 14, 2026. Its market cap has increased by 0.53% in one year.
Market Cap
15.93B
Enterprise Value
36.35B
Revenue
38.86B
Ranking
n/a
PE Ratio
6.22
Stock Price
75.30
Market Cap Chart
Since June 8, 2016, The ACME Laboratories's market cap has decreased from 23.61B to 15.93B, a decrease of -32.53%. That is a compound annual growth rate of -3.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 15.93B | 6.21% |
| Dec 30, 2025 | 15.00B | -5.59% |
| Dec 30, 2024 | 15.89B | -11.65% |
| Dec 28, 2023 | 17.99B | - |
| Dec 29, 2022 | 17.99B | -1.73% |
| Dec 30, 2021 | 18.30B | 15.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 52.37B |
| Renata | 48.21B |
| Unilever Consumer Care | 40.74B |
| Beacon Pharmaceuticals | 22.66B |
| Asiatic Laboratories | 10.66B |
| The IBN SINA Pharmaceutical Industry | 9.84B |
| Orion Pharma | 6.55B |
| Navana Pharmaceuticals | 6.20B |